Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Combined Treatment of Cabergoline With Hydroxychloroquine/Chloroquine for Resistant Prolactinomas

NCT03400865 is registered in ClinicalTrials.gov with Zhebao Wu as lead sponsor.

NCT NCT03400865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03400865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Combined Treatment of Cabergoline With Hydroxychloroquine/Chloroquine for Resistant Prolactinomas
Lead sponsor
Zhebao Wu
Phase
Not applicable
Overall status
Unknown status
Start date
October 25, 2018
Completion date
December 30, 2020
Enrollment
30 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

prolactinoma, resistance, disease